BridgeBio Pharma (NASDAQ:BBIO) is preparing to release its quarterly earnings on Tuesday, 2026-02-24. Here’s a brief overview of what investors should keep in mind before the announcement.
Analysts expect BridgeBio Pharma to report an earnings per share (EPS) of $-0.67.
Anticipation surrounds BridgeBio Pharma’s announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
Overview of Past Earnings
Last quarter the company missed EPS by …